来源: WSJ Markets ↗
Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness
|
暂时无法翻译，请重试。
来源报道重点
Heart disease remains humanity’s top killer, yet for drugmakers and Wall Street, it is becoming one of the hardest places to make money.
在 WSJ Markets 阅读原始报道 ↗